Djurdja Vukicevic

Mississauga, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Treatment characteristics of chronic low back pain patients prescribed Belbuca® and buprenorphine transdermal patches: A retrospective US Medicare claims analysis.

Treatment characteristics of chronic low back pain patients prescribed Belbuca® and buprenorphine transdermal patches: A retrospective US Medicare claims analysis.

Journal: Journal of opioid management
Published: January 08, 2026

Serious treatment-emergent adverse events in chronic low back pain patients treated with buprenorphine or oral opioids: a retrospective commercial claims analysis.

Serious treatment-emergent adverse events in chronic low back pain patients treated with buprenorphine or oral opioids: a retrospective commercial claims analysis.

Journal: Journal of comparative effectiveness research
Published: July 16, 2024

MDMA-assisted therapy and current treatment options for chronic, treatment-resistant, moderate or higher severity post-traumatic stress disorder: Systematic literature review.

MDMA-assisted therapy and current treatment options for chronic, treatment-resistant, moderate or higher severity post-traumatic stress disorder: Systematic literature review.

Journal: PloS one
Published: July 05, 2024

Economic burden and dosing trends of buprenorphine buccal film and transdermal patch in chronic low back pain.

Economic burden and dosing trends of buprenorphine buccal film and transdermal patch in chronic low back pain.

Journal: Pain management
Published: June 28, 2024

Treatment characteristics of chronic low back pain patients treated with buprenorphine buccal film or transdermal patch.

Treatment characteristics of chronic low back pain patients treated with buprenorphine buccal film or transdermal patch.

Journal: Pain management
Published: January 18, 2024

Accuracy of Noninvasive Diagnostic Tests for the Detection of Significant and Advanced Fibrosis Stages in Nonalcoholic Fatty Liver Disease: A Systematic Literature Review of the US Studies.

Accuracy of Noninvasive Diagnostic Tests for the Detection of Significant and Advanced Fibrosis Stages in Nonalcoholic Fatty Liver Disease: A Systematic Literature Review of the US Studies.

Journal: Diagnostics (Basel, Switzerland)
Published: September 12, 2022

Real-world Medicare Healthcare Costs of Patients with Dupuytren's Contracture Treated with Collagenase or Fasciectomy.

Real-world Medicare Healthcare Costs of Patients with Dupuytren's Contracture Treated with Collagenase or Fasciectomy.

Journal: Plastic and reconstructive surgery. Global open
Published: February 17, 2022

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin.

Journal: ClinicoEconomics and outcomes research : CEOR
Published: October 01, 2021

Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment-A retrospective claims analysis.

Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment-A retrospective claims analysis.

Journal: Journal of opioid management
Published: January 11, 2021

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.

Journal: ClinicoEconomics and outcomes research : CEOR
Published: June 29, 2020

The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren's disease undergoing collagenase versus fasciectomy treatment.

The burden of productivity loss of U.S. commercially insured patients diagnosed with Dupuytren's disease undergoing collagenase versus fasciectomy treatment.

Journal: Expert review of pharmacoeconomics & outcomes research
Published: May 16, 2020

Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012-2016.

Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012-2016.

Journal: Journal of pain research
Published: July 10, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026